Who Paid My Doc
Idelvion
Biological Hematology
NDC 69911-867-02
General payments
$841,389
Research payments
$657,814
Through program year 2025, $841,389 in general payments and $657,814 in research payments were reported against Idelvion (Hematology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
12 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $225,356 | 395 |
| 2024 | General | $26,941 | 195 |
| 2023 | General | $29,296 | 319 |
| 2023 | Research | $4,578 | 1 |
| 2022 | General | $50,126 | 407 |
| 2022 | Research | $3,275 | 1 |
| 2021 | General | $93,776 | 345 |
| 2021 | Research | $92,227 | 45 |
| 2020 | General | $140,599 | 251 |
| 2020 | Research | $129,834 | 35 |
| 2019 | General | $275,294 | 447 |
| 2019 | Research | $427,900 | 7 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 21 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 20 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
2,359 general · 89 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.